• Explore /
  • Poster
  • / A randomised phase IIb trial of bevacizumab added to temozolomide ± irinotecan for children with refractory/relapsed neuroblastoma - BEACON-Neuroblastoma, a European Innovative Therapies for Children with Cancer (ITCC) - International Society of Paediatric Oncology Europe Neuroblastoma Group (SIOPEN) trial.

A randomised phase IIb trial of bevacizumab added to temozolomide ± irinotecan for children with refractory/relapsed neuroblastoma - BEACON-Neuroblastoma, a European Innovative Therapies for Children with Cancer (ITCC) - International Society of Paediatric Oncology Europe Neuroblastoma Group (SIOPEN) trial.

Abstract Poster

Authors

null

Lucas Moreno

CNIO, Spanish National Cancer Research Centre, Madrid, Spain

Lucas Moreno , Jennifer Laidler , Veronica Moroz , Cormac Owens , Herve Rubie , Pablo Berlanga , Aurora Castellano , Karsten Nysom , Ruth L Ladenstein , Jochen Rossler , Christian M. Zwaan , Martin Elliott , Guy Makin , Dermot Murphy , Susan A Burchill , Neil Jerome , Raphael F. Rousseau , Pamela Kearns , Keith Wheatley , Andrew DJ Pearson

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2015 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Pediatric Oncology

Track

Pediatric Oncology

Sub Track

Pediatric Solid Tumors

Clinical Trial Registration Number

NCT02308527

Citation

J Clin Oncol 33, 2015 (suppl; abstr TPS10082)

DOI

10.1200/jco.2015.33.15_suppl.tps10082

Abstract #

TPS10082

Poster Bd #

150b

Abstract Disclosures

Similar Posters

First Author: Godfrey Chi-Fung Chan

First Author: Theodore Willis Laetsch

First Author: Shakeel Modak

First Author: Stefan Kasper